A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer

Clinical trial NCT00226941 · TERMINATED

Trial details

NCT number: NCT00226941
Sponsor: George Albert Fisher
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Rectal Cancer Colo-rectal Cancer

Start date: 2004-06-01
Primary completion: 2008-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.